µ¿¹°¿ë ÅëÁõ °ü¸® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ÀûÀÀÁõº°, Á¦Ç°º°, Åõ¿© °æ·Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Veterinary Pain Management Market Size, Share & Trends Analysis Report By Indication (Osteoarthritis, Postoperative Pain, Others), By Product, By Route of Administration, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1654212
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ¿¹°¿ë ÅëÁõ °ü¸® ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Àü ¼¼°è ¼öÀÇÇÐ ÅëÁõ °ü¸® ½ÃÀå ±Ô¸ð´Â 2030³â 38¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.80%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â OA °ü·Ã ÅëÁõ °ü¸®¿¡ ÀÖ¾î ´ÜŬ·ÐÇ×üÀÇ µîÀå, °ñ°üÀý¿° µî µ¿¹°ÀÇ Áúº´ À¯º´·ü Áõ°¡, ¹Ý·Áµ¿¹° »çÀ° ¼ö Áõ°¡, ¼öÀÇ»ç ¼ö Áõ°¡, µ¿¹° ÀÇ·áºñ Áõ°¡ µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ¹Ì±¹ FDA·ÎºÎÅÍ ¹Ý·Á°ßÀÇ OA ÅëÁõ Á¶Àý¿¡ ´ëÇÑ »ç¿ë ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. ¶ÇÇÑ, ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­, ¹Ý·Áµ¿¹° Àα¸ Áõ°¡, ´ë±â¾÷ÀÇ ³ë·Â °­È­, µ¿¹° ÀÇ·áºñ »ó½Â µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ¹Ý·Áµ¿¹° º¸ÇèÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¼öÀÇ»çÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, AVMA¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¼öÀÇ»ç ¼ö´Â ÃÑ 127,131¸íÀÔ´Ï´Ù. ¼öÀÇ»çµéÀº ÇöÀç ±Þ¼º ¶Ç´Â ¸¸¼º ÅëÁõ¿¡ °ü°è¾øÀÌ µ¿¹°ÀÇ ÅëÁõÀ» ½Äº°ÇÏ°í ´ëóÇÒ ¼ö ÀÖ´Â µµ±¸¿Í Áö½ÄÀ» ´õ Àß °®Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¿¹°ÀÇ ÅëÁõ Àνİú °ü¸®¿¡ ´ëÇÑ ¼öÀÇ»ç ±³À°¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ¼öÀǰú´ëÇÐÀº ÅëÁõ °ü¸®¸¦ Ä¿¸®Å§·³¿¡ Æ÷ÇÔ½Ã۰í, ¼öÀÇ»çµéÀº Æò»ý±³À° ÇÁ·Î±×·¥À» ÅëÇØ Ãֽбâ¼ú°ú ¾à¹°À» ½ÀµæÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¼öÀÇÇÐ ÅëÁõ °ü¸® ½ÃÀåÀ» ÁÖµµÇÏ´Â ¼öÀÇ»ç ¼öÀÇ»ç ¼öÀÇ Áõ°¡´Â ´õ ³ªÀº Ä¡·á¿Í µ¿¹°ÀÇ Çʿ信 ´ëÇÑ ÀÌÇØ¿¡ ´ëÇÑ ±àÁ¤ÀûÀÎ º¯È­¸¦ ¹Ý¿µÇϸç, ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­¿Í Á¤¼­Àû, ½ÅüÀû À£ºù¿¡ ´ëÇÑ ÀνÄÀÌ È®»êµÇ´Â Ãß¼¼¿Í ÀÏÄ¡ÇÕ´Ï´Ù.

¼öÀÇ»çÀÇ ÅëÁõ °ü¸®´Â ƯÈ÷ ¾Ï°ú °°ÀÌ ÅëÁõÀÌ ½É°¢ÇÑ Áõ»óÀ¸·Î ³ªÅ¸³ª´Â Áúº´¿¡¼­ ¹Ý·Áµ¿¹°À» µ¹º¸´Â µ¥ ÀÖ¾î ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. 10¼¼ ÀÌ»ó ¹Ý·Á°ßÀÇ ¾à 50%°¡ ¾Ï¿¡ °É¸®¸ç, ¹Ý·Á°ßÀÇ ¾Ï ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼öÀÇÇÐ ºÐ¾ß¿¡¼­ È¿°úÀûÀÎ ÅëÁõ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °³ÀÇ ¾ÏÀº »ç¶÷°ú ºñ½ÁÇÑ ºñÀ²·Î ¹ß»ýÇÕ´Ï´Ù. ¸²ÇÁÁ¾°ú °°ÀÌ °³º¸´Ù °í¾çÀ̰¡ ´õ ÀÚÁÖ °É¸®´Â ¾Ïµµ ÀÖ½À´Ï´Ù. ¾Ï¿¡ °É¸° ¹Ý·Á°ßÀÇ ÅëÁõ °ü¸®¸¦ µ½±â À§ÇØ ¼öÀÇ»ç´Â ÁøÅëÁ¦, Ç׿°ÁõÁ¦ µîÀÇ ÀǾàǰ°ú ħ¼ú, ¹°¸®Ä¡·á µîÀÇ º¸¿Ï¿ä¹ýÀ» º´ÇàÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

¶ÇÇÑ, ÁÖ¿ä M&A, Áö¿ª È®Àå, Á¦Ç° Ãâ½Ã µîÀº ½ÃÀå¿¡¼­ÀÇ ¹ßÆÇÀ» ¸¶·ÃÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù, Ceva´Â ¹Ý·Áµ¿¹° ÷´Ü Ä¡·áÁ¦¸¦ Àü¹®À¸·Î ÇÏ´Â ´ëÇü »ý¸í°øÇÐ ±â¾÷ ½ºÄ«¿ìÆ® ¹ÙÀÌ¿À(Scout Bio)¸¦ ÀμöÇß½À´Ï´Ù. ÀÌ Àμö´Â ¼¼¹Ù°¡ ¹Ý·Áµ¿¹°ÀÇ ¸¸¼ºÁúȯÀ» Ä¡·áÇϱâ À§ÇÑ ´ÜŬ·ÐÇ×ü ¹× À¯ÀüÀÚ Ä¡·á¿Í °°Àº ȹ±âÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®º¸ÇÒ ¼ö ÀÖ°Ô µÈ Áß¿äÇÑ ÁøÀüÀÔ´Ï´Ù.

µ¿¹° ÅëÁõ °ü¸® ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼öÀÇ ÅëÁõ °ü¸® ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¼öÀÇ ÅëÁõ °ü¸® ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¼öÀÇ ÅëÁõ °ü¸® ½ÃÀå : ÀûÀÀÁõ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¼öÀÇ ÅëÁõ °ü¸® ½ÃÀå : µ¿¹° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¼öÀÇ ÅëÁõ °ü¸® ½ÃÀå : Åõ¿© °æ·Î ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ¼öÀÇ ÅëÁõ °ü¸® ½ÃÀå : ±¸ÀÔ ¹æ½Ä ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå ¼öÀÇ ÅëÁõ °ü¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦10Àå ¼öÀÇ ÅëÁõ °ü¸® ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦11Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Veterinary Pain Management Market Growth & Trends:

The global veterinary pain management market size is expected to reach USD 3.82 billion in 2030 and is projected to grow at a CAGR of 6.80% from 2025 to 2030. The primary drivers of market growth include the advent of monoclonal antibodies in OA associated pain control, rising prevalence of diseases in animals such as osteoarthritis, rising pet ownership, increasing number of veterinarians, and increasing animal health expenditure. In May 2023, Zoetis's Librela mAb received the U.S. FDA approval for use in dog OA pain control. Moreover, pet insurance adoption is increasing due to a number of factors, including pet humanization, a growing pet population, greater initiatives by major companies, and rising veterinary care expenses.

Increasing number of veterinarians is expected to fuel the market growth. For instance, according to AVMA, there were a total of 127,131 vet practitioners in the U.S. veterinarians are now better equipped with tools and knowledge to identify and address pain in animals, whether it's acute or chronic. Moreover, there's a greater emphasis on educating veterinarians about recognizing and managing pain in animals. Veterinary schools are incorporating pain management into their curricula, and continuing education programs keep practicing veterinarians up-to-date on the latest techniques and medications. Overall, the increasing number of veterinarians driving the veterinary pain management market reflects a positive shift towards better care and understanding of animals' needs, aligning with the broader trend of humanizing pets and recognizing their emotional and physical well-being.

Veterinary pain management has become a crucial aspect of pet care, particularly with conditions such as cancer, where pain can be a significant symptom. With the increase in cancer cases among dogs, there's likely a corresponding increase in the demand for effective pain management solutions in veterinary practice. Approximately fifty percent of dogs over the age of ten develop cancer. Cancer in dogs occurs at a rate similar to that of humans. There are certain cancers that affect cats more frequently than dogs, like lymphoma. In order to help manage pain in dogs with cancer, veterinarians frequently combine pharmaceuticals, such as analgesics and anti-inflammatory medicines, with complementary therapies, such as acupuncture and physical therapy.

Furthermore, key mergers and acquisitions, regional expansions, product launches, etc., to increase their foothold in the market. For instance, in January 2024, Ceva acquired Scout Bio, a leading biotechnology firm specializing in advanced therapies for pets. This acquisition marks a substantial advancement for Ceva, granting access to groundbreaking treatments such as monoclonal antibodies and gene therapy aimed to tackle chronic pet diseases.

Veterinary Pain Management Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Veterinary Pain Management Market Variables, Trends, & Scope

Chapter 4. Veterinary Pain Management Market: Product Estimates & Trend Analysis

Chapter 5. Veterinary Pain Management Market: Indication Estimates & Trend Analysis

Chapter 6. Veterinary Pain Management Market: Animal Estimates & Trend Analysis

Chapter 7. Veterinary Pain Management Market: Route of Administration Estimates & Trend Analysis

Chapter 8. Veterinary Pain Management Market: Mode of Purchase Estimates & Trend Analysis

Chapter 9. Veterinary Pain Management Market: End Use Estimates & Trend Analysis

Chapter 10. Veterinary Pain Management Market: Regional Estimates & Trend Analysis

Chapter 11. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â